Skip to main content
NCBI home page
Cellular & Molecular Biology Letters logoLink to Cellular & Molecular Biology Letters
. 2009 Aug 14;15(1):13. doi: 10.2478/s11658-009-0033-1

Treatment with TNF-α and IFN-γ alters the activation of SER/THR protein kinases and the metabolic response to IGF-I in mouse c2c12 myogenic cells

Katarzyna Grzelkowska-Kowalczyk 1,✉, Wioletta Wieteska-Skrzeczyńska 1
PMCID: PMC6275934  PMID: 19685010

Abstract

The aim of this study was to compare the effects of TNF-α, IL-1β and IFN-γ on the activation of protein kinase B (PKB), p70S6k, mitogen-activated protein kinase (MAPK) and p90rsk, and on IGF-I-stimulated glucose uptake and protein synthesis in mouse C2C12 myotubes. 100 nmol/l IGF-I stimulated glucose uptake in C2C12 myotubes by 198.1% and 10 ng/ml TNF-α abolished this effect. Glucose uptake in cells differentiated in the presence of 10 ng/ml IFN-γ increased by 167.2% but did not undergo significant further modification upon the addition of IGF-I. IGF-I increased the rate of protein synthesis by 249.8%. Neither TNF-α nor IFN-γ influenced basal protein synthesis, but both cytokines prevented the IGF-I effect. 10 ng/ml IL-1β did not modify either the basal or IGF-I-dependent glucose uptake and protein synthesis. With the exception of TNF-α causing an 18% decrease in the level of PKB protein, the cellular levels of PKB, p70S6k, p42MAPK, p44MAPK and p90rsk were not affected by the cytokines. IGF-I caused the phosphorylation of PKB (an approximate 8-fold increase above the basal value after 40 min of IGF-I treatment), p42MAPK (a 2.81-fold increase after 50 min), and the activation of p70S6k and p90rsk, manifesting as gel mobility retardation. In cells differentiated in the presence of TNF-α or IFN-γ, this IGF-I-mediated PKB and p70S6k phosphorylation was significantly diminished, and the increase in p42MAPK and p90rsk phosphorylation was prevented. The basal p42MAPK phosphorylation in C2C12 cells treated with IFN-γ was high and comparable with the activation of this kinase by IGF-I. Pretreatment of myogenic cells with IL-1β did not modify the IGF-I-stimulated phosphorylation of PKB, p70S6k, p42MAPK and p90rsk. In conclusion: i) TNF-α and IFN-γ, but not IL-1β, if present in the extracellular environment during C2C12 myoblast differentiation, prevent the stimulatory action of IGF-I on protein synthesis. ii) TNF-α- and IFN-γ-induced IGF-I resistance of protein synthesis could be associated with the decreased phosphorylation of PKB and p70S6k. iii) The activation of glucose uptake in C2C12 myogenic cells treated with IFN-γ is PKB independent. iv) The similar effects of TNF-α and IFN-γ on the signalling and action of IGF-I on protein synthesis in myogenic cells could suggest the involvement of both of these cytokines in protein loss in skeletal muscle.

Key words: Cytokines, Glucose transport, IGF-I resistance, Protein synthesis, Signalling pathways

Full Text

The Full Text of this article is available as a PDF (3.6 MB).

Abbreviations used

IFN-γ

interferon-γ

IGF-I

insulin-like growth factor-I

IL-1β

interleukin-1β

MAPK

mitogen-activated protein kinase

PI-3K

phosphatidylinositol 3-kinase

PKB (Akt)

protein kinase B/Akt

TNF-α

tumour necrosis factor-α

References

  • 1.Costelli P., Tullio R.D., Baccino F.M., Melloni E. Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br. J. Cancer. 2001;84:946–950. doi: 10.1054/bjoc.2001.1696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fairfield W.P., Treat M., Rosenthal D.I., Frontera W., Stanley T., Cocroran C., Costello M., Parlman K., Schoenfeld D., Klibanski A., Grinspoon S. Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting. J. Appl. Physiol. 2001;90:2166–2171. doi: 10.1152/jappl.2001.90.6.2166. [DOI] [PubMed] [Google Scholar]
  • 3.Minnaard R., Drost M.R., Wagenmakers A.J., van Kranenburg G.P., Kuipers H., Hesselink M.K. Skeletal muscle wasting and contractile performance in septic rats. Muscle Nerve. 2005;31:339–348. doi: 10.1002/mus.20268. [DOI] [PubMed] [Google Scholar]
  • 4.Pfitzenmaier J., Vessella R., Higano C.S., Noteboom J.L., Wallace D., Corey E. Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer. 2003;97:1211–1216. doi: 10.1002/cncr.11178. [DOI] [PubMed] [Google Scholar]
  • 5.Acharyya S., Ladner K.J., Nelsen L.L., Damrauer J., Reiser P.J., Swoap S., Guttridge D.C. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Invest. 2004;114:370–378. doi: 10.1172/JCI20174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.De Rossi M., Bernasconi P., Baggi F., de Waal M.R., Mantegazza R. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int. Immunol. 2000;12:1329–1332. doi: 10.1093/intimm/12.9.1329. [DOI] [PubMed] [Google Scholar]
  • 7.Knobler H., Schatter A. TNF-α, chronic hepatitis C and diabetes: a novel triad. Q. J. Med. 2005;98:1–6. doi: 10.1093/qjmed/hci001. [DOI] [PubMed] [Google Scholar]
  • 8.Baracos V.E. Regulation of skeletal-muscle-protein turnover in cancerassociated cachexia. Nutrition. 2000;16:1015–1018. doi: 10.1016/S0899-9007(00)00407-X. [DOI] [PubMed] [Google Scholar]
  • 9.Pedersen M., Bruunsgaard H., Weis N., Hendel H.W., Andreassen B.U., Eldrup E., Dela F., Pedersen B.K. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech. Ageing Dev. 2003;124:495–502. doi: 10.1016/S0047-6374(03)00027-7. [DOI] [PubMed] [Google Scholar]
  • 10.Figarella-Branger D., Civatte M., Bartoli C., Pellissier J.F. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve. 2003;28:659–682. doi: 10.1002/mus.10462. [DOI] [PubMed] [Google Scholar]
  • 11.Zoico E., Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function. Nutr. Rev. 2002;60:39–51. doi: 10.1301/00296640260085949. [DOI] [PubMed] [Google Scholar]
  • 12.Zhang Y., Pilon G., Marette A., Baracos V.E. Cytokines and endotoxin induce cytokine receptors in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2000;279:196–205. doi: 10.1152/ajpendo.2000.279.1.E196. [DOI] [PubMed] [Google Scholar]
  • 13.Fernandez-Celemin L., Pasko N., Blomart V., Thissen J.-P. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-α. Am. J. Physiol. Endocrinol. Metab. 2002;283:1279–1290. doi: 10.1152/ajpendo.00054.2002. [DOI] [PubMed] [Google Scholar]
  • 14.Alvarez B., Quinn L.S., Busquets S., Quiles M.T., Lopez-Soriano F.J., Argiles J.M. Tumor necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells. Biochim. Biophys. Acta. 2002;1542:66–72. doi: 10.1016/S0167-4889(01)00167-7. [DOI] [PubMed] [Google Scholar]
  • 15.Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., Hotamisligil G.S. A central role of JNK in obesity and insulin resistance. Nature. 2002;420:333–336. doi: 10.1038/nature01137. [DOI] [PubMed] [Google Scholar]
  • 16.Musaro A., McCullagh K., Paul A., Houghton L., Dobrowolny G., Molinaro M., Barton E.R., Rosenthal N. Localized Igf-1 trangene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 2001;27:195–200. doi: 10.1038/84839. [DOI] [PubMed] [Google Scholar]
  • 17.Kim J.J., Accili D. Signalling through IGF-I and insulin receptors: where is the specificity? Growth Horm. IGF Res. 2002;12:84–90. doi: 10.1054/ghir.2002.0265. [DOI] [PubMed] [Google Scholar]
  • 18.Rommel C., Bodine S.C., Clarke B.A., Rossman R., Nunez L., Stitt T.N., Yancopoulos G.D., Glass D.J. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell. Biol. 2001;3:1009–1013. doi: 10.1038/ncb1101-1009. [DOI] [PubMed] [Google Scholar]
  • 19.Ciaraldi T.P., Carter L., Rehman N., Mohideen P., Mudaliar S., Henry R.R. Insulin and insulin-like growth factor-1 action on human skeletal muscle: preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects. Metabolism. 2002;51:1171–1179. doi: 10.1053/meta.2002.34050. [DOI] [PubMed] [Google Scholar]
  • 20.Peruzzi F., Prisco M., Morione A., Valentinis B., Baserga R. Antiapoptotic signalling of the insulin-like growth factor-I receptor through mitochondrial translocation of c-rar and Nedd4. J. Biol. Chem. 2001;276:25990–25996. doi: 10.1074/jbc.M103188200. [DOI] [PubMed] [Google Scholar]
  • 21.Grzelkowska-Kowalczyk K., Wieteska-Skrzeczyńska W. Exposure to TNF-α but not IL-1β impairs insulin-dependent phosphorylation of protein kinase B and p70S6k in mouse C2C12 myogenic cells. Pol. J. Vet. Sci. 2006;9:1–10. [PubMed] [Google Scholar]
  • 22.Grzelkowska-Kowalczyk K., Wieteska W. The impairment of IGF-Istimulated protein synthesis and activation of protein kinase B, p70S6k, MAP kinase, and p90rsk in mouse C2C12 myogenic cells exposed to high glucose and high insulin. Pol. J. Vet. Sci. 2005;3:241–250. [PubMed] [Google Scholar]
  • 23.Frost R.A., Nystrom G.J., Jefferson L.S., Lang C.H. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2007;292:501–512. doi: 10.1152/ajpendo.00359.2006. [DOI] [PubMed] [Google Scholar]
  • 24.Williamson D.L., Kimball S.R., Jefferson L.S. Acute treatment with TNF-{alpha} attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism. Am. J. Physiol. Endocrinol. Metab. 2005;289:95–104. doi: 10.1152/ajpendo.00397.2004. [DOI] [PubMed] [Google Scholar]
  • 25.Lang C.H., Pruznak A.M., Frost R.A. TNFalpha mediates sepsisinduced impairment of basal and leucine-stimulated signalling via S6K1 and eIF4E in cardiac muscle. J. Cell. Biochem. 2005;94:419–431. doi: 10.1002/jcb.20311. [DOI] [PubMed] [Google Scholar]
  • 26.Plaisance I., Morandi C., Murigande C., Brink M. TNF-{alpha} increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK. Am. J. Physiol. Endocrinol. Metab. 2008;294:241–250. doi: 10.1152/ajpendo.00129.2007. [DOI] [PubMed] [Google Scholar]
  • 27.Los V.T., Haagsman H.P.U. TNF-[alpha] inhibits adult fast myosin accumulation in myotubes. Cytokine. 2006;35:154–158. doi: 10.1016/j.cyto.2006.07.022. [DOI] [PubMed] [Google Scholar]
  • 28.Petersen A.M., Plomgaard P., Fischer C.P., Ibfelt T., Pedersen B.K., van Hall G. Acute moderate elevation of TNF-a does not effect systemic and skeletal muscle protein turnover in healthy humans. J. Clin. Endocrinol. Metab. 2009;94:294–299. doi: 10.1210/jc.2008-1110. [DOI] [PubMed] [Google Scholar]
  • 29.Chen Y.-W., Shi R., Geraci N., Shrestha S., Gordish-Dressman H., Pachman L.M. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. B.M.C. Immunol. 2008;9:43–55. doi: 10.1186/1471-2172-9-43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Broussard S.R., McCusker R.H., Novakofski J.E., Strle K., Shen W.H., Johnson R.W., Freund G.G., Dantzer R., Kelley K.W. Cytokinehormone interactions: tumor necrosis factor α impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Endocrinology. 2003;144:2988–2996. doi: 10.1210/en.2003-0087. [DOI] [PubMed] [Google Scholar]
  • 31.Keller P., Moller K., Krabbe K., Pedersen B. Circulating adiponectin levels during human endotoxemia. Clin. Exp. Immunol. 2003;134:107–110. doi: 10.1046/j.1365-2249.2003.02264.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Carrol E., Thomson A., Jones A., Jeffers G., Hart C. A predominantly anti-inflammaroty cytokine profile is associated with disease severity in meningococcal sepsis. Intensive Care Med. 2005;31:1415–1419. doi: 10.1007/s00134-005-2787-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Frost R.A., Lang C.H. Regulation of muscle growth by pathogen associated molecules. J. Anim. Sci. 2008;86(suppl.14):E84–93. doi: 10.2527/jas.2007-0483. [DOI] [PubMed] [Google Scholar]
  • 34.Foulstone E.J., Huser C., Crown A.L., Holly J.M., Steward C.E. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha. Exp. Cell Res. 2004;294:223–235. doi: 10.1016/j.yexcr.2003.10.034. [DOI] [PubMed] [Google Scholar]
  • 35.Tolosa L., Morla M., Iglesias A., Busquets X., Ilado J., Olmos G. IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity. Cell Signal. 2005;17:1333–1342. doi: 10.1016/j.cellsig.2005.02.001. [DOI] [PubMed] [Google Scholar]
  • 36.Smith M.A., Moylan J.S., Smith J.D., Li W., Reid M.B. IFN-gamma does not mimic the catabolic effects of TNF-alpha. Am. J. Physiol. Cell. Physiol. 2007;293:1947–1952. doi: 10.1152/ajpcell.00269.2007. [DOI] [PubMed] [Google Scholar]
  • 37.Gual P., Le Marchand-Brustel Y., Tanti J.F. Positive and negative regulation of insulin signalling through IRS-1 phosphorylation. Biochimie. 2005;87:99–109. doi: 10.1016/j.biochi.2004.10.019. [DOI] [PubMed] [Google Scholar]
  • 38.De Alvaro C., Teruel T., Hernandez R., Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a MAPK-dependent manner. J. Biol. Chem. 2004;279:17170–17178. doi: 10.1074/jbc.M312021200. [DOI] [PubMed] [Google Scholar]
  • 39.Medina E.A., Afsari R.R., Ravid T., Castillo S.S., Erickson K.L., Goldkorn T. Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology. 2005;146:2726–2735. doi: 10.1210/en.2004-1074. [DOI] [PubMed] [Google Scholar]
  • 40.Yamaguchi K., Higashiura K., Ura N., Murakami H., Hyakukoku M., Furuhashi M., Shimamoto K. The effect of tumor necrosis factor-α in tissue specificity and selectivity to insulin signalling. Hypertens. Res. 2003;26:389–396. doi: 10.1291/hypres.26.389. [DOI] [PubMed] [Google Scholar]
  • 41.Mourkioti F., Rosenthal N. IGF-I, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol. 2005;26:535–542. doi: 10.1016/j.it.2005.08.002. [DOI] [PubMed] [Google Scholar]
  • 42.Frost R.A., Nystrom G.J., Lang C.H. Tumor necrosis factor-α decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway. Endocrinology. 2003;144:1770–1779. doi: 10.1210/en.2002-220808. [DOI] [PubMed] [Google Scholar]
  • 43.Khanna S., Roy S., Packer L., Sen C.K. Cytokine-induced glucose uptake in skeletal muscle: redox regulation and the role of α-lipoic acid. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1999;276:1327–1333. doi: 10.1152/ajpregu.1999.276.5.R1327. [DOI] [PubMed] [Google Scholar]
  • 44.Wieteska-Skrzeczyńska W., Grzelkowska-Kowalczyk K. The impairment of IGF-I-stimulated differentiation of mouse C2C12 myogenic cells exposed to TNF-α, IL-1β and IFN-γ. J. Physiol. Pharmacol. 2006;57(suppl.2):242. [Google Scholar]

Articles from Cellular & Molecular Biology Letters are provided here courtesy of BMC

RESOURCES